Technical Analysis for DDDD - 4D Pharma Plc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Historical DDDD trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Stochastic Buy Signal | Bullish | 0.00% | |
| Multiple of Ten Bearish | Other | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Multiple of Ten Bearish | Other | 1.55% | |
| Wide Bands | Range Expansion | 1.55% | |
| Oversold Stochastic | Weakness | 1.55% | |
| Bullish Engulfing | Bullish | -2.48% | |
| Multiple of Ten Bullish | Other | -2.48% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Fell Below Previous Day's Low | 41 minutes ago |
| Down 3% | 41 minutes ago |
| Down 2% | 41 minutes ago |
| Down 1% | 41 minutes ago |
| Up 3% | 41 minutes ago |
Get a Trading Assistant
4D Pharma Plc Description
4D pharma plc (4D), formerly Schosween 18 Limited, is a United Kingdom-based pharmaceutical company focusing on developing various projects targeting new therapeutic areas. The principal activity of the Company is research and development of pharmaceutical products in new live biotherapeutic areas. The Company has developed its research to build MicroRx, which is a discovery methodology that is able to rationally select those bacteria that have a precise and evolved therapeutic effect. Its MicroRx methodology offers a pipeline of approximately 10 therapeutic programs covering autoimmune diseases, central nervous system (CNS) disorders and cancer. The Company uses MicroRx to develop its programs into the clinic and has approximately two programs in patient trials. The Company focuses on immune conditions, such as pediatric Crohn's, pediatric colitis and irritable bowel syndrome.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Medicine Pipe Clinic Disease Cancer Medical Specialties Diseases Targeting Clinical Medicine Rtt Autoimmune Diseases Disorders Pharmaceutical Products Bacteria Evolve Abdominal Pain Crohn's Disease Therapeutic Effect
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 154.0 |
| 52 Week Low | 56.0 |
| Average Volume | 1,753,299 |
| 200-Day Moving Average | 92.30 |
| 50-Day Moving Average | 66.43 |
| 20-Day Moving Average | 70.92 |
| 10-Day Moving Average | 63.68 |
| Average True Range | 5.36 |
| ADX | 24.23 |
| +DI | 15.27 |
| -DI | 26.63 |
| Chandelier Exit (Long, 3 ATRs) | 77.23 |
| Chandelier Exit (Short, 3 ATRs) | 72.64 |
| Upper Bollinger Bands | 88.37 |
| Lower Bollinger Band | 53.46 |
| Percent B (%b) | 0.16 |
| BandWidth | 49.24 |
| MACD Line | -2.75 |
| MACD Signal Line | -0.80 |
| MACD Histogram | -1.942 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 65.25 | ||||
| Resistance 3 (R3) | 65.27 | 63.23 | 64.23 | ||
| Resistance 2 (R2) | 63.23 | 61.67 | 63.23 | 63.88 | |
| Resistance 1 (R1) | 61.17 | 60.70 | 62.20 | 61.15 | 63.54 |
| Pivot Point | 59.13 | 59.13 | 59.65 | 59.13 | 59.13 |
| Support 1 (S1) | 57.07 | 57.57 | 58.10 | 57.05 | 54.66 |
| Support 2 (S2) | 55.03 | 56.60 | 55.03 | 54.32 | |
| Support 3 (S3) | 52.97 | 55.03 | 53.98 | ||
| Support 4 (S4) | 52.95 |
